
Advaxis ADXS
Geschäftsbericht 2023
hinzugefügt 16.04.2024
Advaxis EV/EBITDA 2011-2026 | ADXS
EV/EBITDA Jährlich Advaxis
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -82.4 | 0.247 | 1.49 | 0.334 | -0.999 | -2.39 | -5.61 | -1.85 | 0.0537 | -1.62 | -2.57 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.49 | -82.4 | -8.66 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
17.3 | $ 21.94 | 2.45 % | $ 1.03 B | ||
|
I-Mab
IMAB
|
595 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | ||
|
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
29.4 | $ 0.91 | 1.96 % | $ 6.69 M | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
4.22 K | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
-21.1 | $ 22.73 | 3.51 % | $ 3.77 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | ||
|
Esperion Therapeutics
ESPR
|
-2.15 | $ 1.98 | 3.4 % | $ 412 M | ||
|
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | ||
|
Galectin Therapeutics
GALT
|
-1.92 | $ 2.46 | 5.58 % | $ 157 M | ||
|
Greenwich LifeSciences
GLSI
|
-47.7 | $ 24.14 | -0.29 % | $ 314 M | ||
|
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | ||
|
Heron Therapeutics
HRTX
|
-4.31 | $ 1.23 | 2.94 % | $ 205 M | ||
|
ImmuCell Corporation
ICCC
|
23.1 | $ 8.22 | -1.56 % | $ 74.2 M | ||
|
Allakos
ALLK
|
-1.56 | - | - | $ 28.6 M | ||
|
InflaRx N.V.
IFRX
|
-3.65 | $ 1.56 | 5.07 % | $ 152 M | ||
|
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-20.4 | - | -11.43 % | $ 502 K | ||
|
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - | ||
|
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M | ||
|
Innate Pharma S.A.
IPHA
|
-6.65 | $ 1.4 | 1.09 % | $ 235 M | ||
|
Aeterna Zentaris
AEZS
|
4.4 | - | 5.93 % | $ 314 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-5.59 | - | -2.5 % | $ 5.88 M | ||
|
Applied Therapeutics
APLT
|
-0.476 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-1.56 | - | -39.0 % | $ 4.57 M | ||
|
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | ||
|
Aravive
ARAV
|
-0.158 | - | -13.39 % | $ 1.45 M | ||
|
Inventiva S.A.
IVA
|
-9.77 | $ 5.11 | -0.78 % | $ 138 M | ||
|
Jaguar Health
JAGX
|
-0.625 | $ 0.33 | -13.82 % | $ 770 K | ||
|
Aridis Pharmaceuticals
ARDS
|
-0.807 | - | 17.91 % | $ 11.1 M | ||
|
BioNTech SE
BNTX
|
4.1 | $ 102.65 | -2.66 % | $ 27.2 B | ||
|
Avenue Therapeutics
ATXI
|
0.871 | - | -52.27 % | $ 4.45 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | ||
|
KalVista Pharmaceuticals
KALV
|
-3.44 | $ 20.05 | 2.11 % | $ 1.08 B | ||
|
Aquestive Therapeutics
AQST
|
-7.26 | $ 4.14 | 1.59 % | $ 443 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-4.86 | $ 23.65 | 1.68 % | $ 3.01 B | ||
|
Ayala Pharmaceuticals
AYLA
|
0.785 | - | - | $ 7.46 M | ||
|
Autolus Therapeutics plc
AUTL
|
-1.38 | $ 1.44 | -0.35 % | $ 383 M | ||
|
Aptose Biosciences
APTO
|
388 | - | -45.71 % | $ 1.2 M | ||
|
AstraZeneca PLC
AZN
|
76.5 | - | - | $ 96.9 B | ||
|
AVROBIO
AVRO
|
0.957 | - | 1083.1 % | $ 745 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
19.4 | $ 230.83 | -0.19 % | $ 4.22 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-43.1 | $ 2.92 | 0.24 % | $ 4.81 M | ||
|
Eli Lilly and Company
LLY
|
143 | $ 881.74 | -0.28 % | $ 791 B | ||
|
BioDelivery Sciences International
BDSI
|
8 | - | -4.8 % | $ 255 M |